Regeneron Pharmaceuticals Inc (REGN) - Financial and Strategic SWOT Analysis Review

1 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Allergan Inc
  • Amgen Inc
  • Bayer AG
  • Eli Lilly and Co
  • Genentech Inc
  • MORE
Regeneron Pharmaceuticals Inc (REGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Regeneron Pharmaceuticals Inc (Regeneron) is a biopharmaceutical company, which discovers, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. The company’s six US FDA-approved medicines and product candidates in development help patients with eye diseases, asthma, pain, cancer and heart, allergic, inflammatory and infectious diseases. It develops products based on its VelociSuite technology platforms, which include VelociGene, VelocImmune, VelociMouse, VelociMab and other related technologies. Regeneron also has various product candidates under clinical development for treating asthma, pain, cancer, atopic dermatitis and infectious diseases. It has subsidiaries in Belgium, Spain, Ireland, the Netherlands, the US and the UK. Regeneron is headquartered in Tarrytown, New York, the US.

Regeneron Pharmaceuticals Inc Key Recent Developments

Mar 21, 2018: Regeneron Genetics Center Publication in New England Journal of Medicine Identifies New Genetic Variant Providing Protection from Chronic Liver Disease
Mar 13, 2018: Teen Scientists Win $1.8 Million at Regeneron Science Talent Search 2018 with Top Awards for Novel Research on Crop Blight, Vaping and Rare Disease
Feb 12, 2018: Regeneron Announces Appointment of Marion McCourt as Senior Vice President and Head of Commercial
Feb 08, 2018: Regeneron Reports Fourth Quarter and Full Year 2017 Financial Results
Jan 08, 2018: Regeneron Forms Consortium of Leading Life Sciences Companies to Accelerate Largest Widely-Available 'Big Data' Human Sequencing Resource with UK Biobank

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Allergan Inc
  • Amgen Inc
  • Bayer AG
  • Eli Lilly and Co
  • Genentech Inc
  • MORE
Section 1 - About the Company
  • Regeneron Pharmaceuticals Inc - Key Facts
  • Regeneron Pharmaceuticals Inc - Key Employees
  • Regeneron Pharmaceuticals Inc - Key Employee Biographies
  • Regeneron Pharmaceuticals Inc - Major Products and Services
  • Regeneron Pharmaceuticals Inc - History
  • Regeneron Pharmaceuticals Inc - Company Statement
  • Regeneron Pharmaceuticals Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Regeneron Pharmaceuticals Inc - Business Description
  • Product Category: Arcalyst
  • Overview
  • Performance
  • Product Category: Dupixent
  • Overview
  • Product Category: Eylea
  • Overview
  • Performance
  • Product Category: Kevzara
  • Overview
  • Product Category: Praluent
  • Overview
  • Product Category: Zaltrap
  • Overview
  • R&D Overview
  • Regeneron Pharmaceuticals Inc - Corporate Strategy
  • Regeneron Pharmaceuticals Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Regeneron Pharmaceuticals Inc - Strengths
  • Regeneron Pharmaceuticals Inc - Weaknesses
  • Regeneron Pharmaceuticals Inc - Opportunities
  • Regeneron Pharmaceuticals Inc - Threats
  • Regeneron Pharmaceuticals Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Regeneron Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Regeneron Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Regeneron Pharmaceuticals Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Mar 21, 2018: Regeneron Genetics Center Publication in New England Journal of Medicine Identifies New Genetic Variant Providing Protection from Chronic Liver Disease
  • Mar 13, 2018: Teen Scientists Win $1.8 Million at Regeneron Science Talent Search 2018 with Top Awards for Novel Research on Crop Blight, Vaping and Rare Disease
  • Feb 12, 2018: Regeneron Announces Appointment of Marion McCourt as Senior Vice President and Head of Commercial
  • Jan 08, 2018: Regeneron Forms Consortium of Leading Life Sciences Companies to Accelerate Largest Widely-Available 'Big Data' Human Sequencing Resource with UK Biobank
  • Dec 27, 2017: Merus Announces the U.S. Court of Appeals for the Federal Circuit Denies Regeneron's Petition to Rehear the Panel's Decision Affirming Merus' Inequitable Conduct Claim Against Regeneron
  • Dec 27, 2017: Merus Announces the U.S. Court of Appeals for the Federal Circuit Denies Regeneron's Petition to Rehear the Panel's Decision Affirming Merus' Inequitable Conduct Claim Against Regeneron
  • Nov 08, 2017: Regeneron Reports Third Quarter 2017 Financial and Operating Results
  • Aug 03, 2017: Regeneron Reports Second Quarter 2017 Financial and Operating Results
  • Jul 28, 2017: U.S. Court of Appeals for the Federal Circuit Affirms Merus’ Inequitable Conduct Claim Against Regeneron
  • Jun 21, 2017: Regeneron Recognized on The Civic List of the Most Community-Minded Companies in the United States
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Regeneron Pharmaceuticals Inc, Key Facts
  • Regeneron Pharmaceuticals Inc, Key Employees
  • Regeneron Pharmaceuticals Inc, Key Employee Biographies
  • Regeneron Pharmaceuticals Inc, Major Products and Services
  • Regeneron Pharmaceuticals Inc, History
  • Regeneron Pharmaceuticals Inc, Other Locations
  • Regeneron Pharmaceuticals Inc, Subsidiaries
  • Regeneron Pharmaceuticals Inc, Key Competitors
  • Regeneron Pharmaceuticals Inc, Ratios based on current share price
  • Regeneron Pharmaceuticals Inc, Annual Ratios
  • Regeneron Pharmaceuticals Inc, Annual Ratios
  • Regeneron Pharmaceuticals Inc, Annual Ratios
  • Regeneron Pharmaceuticals Inc, Interim Ratios
  • Regeneron Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Regeneron Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Regeneron Pharmaceuticals Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Regeneron Pharmaceuticals Inc, Performance Chart (2013 - 2017)
  • Regeneron Pharmaceuticals Inc, Ratio Charts
  • Regeneron Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Regeneron Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Sanofi
  • Pfizer Inc
  • Novartis AG
  • Merck & Co Inc
  • Genentech Inc
  • Eli Lilly and Co
  • Bayer AG
  • Amgen Inc
  • Allergan Inc
  • Abbott Laboratories
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll